Isabel Mestres: I wish I were one of the 12 women granted $20 million by Melinda French Gates
Isabel Mestres recently shared a post on LinkedIn:
“I wish I were one of the 12 women granted $20 million by Melinda French Gates. I would have distributed it among C/Can cities’ local CSOs to strengthen their organizational capacity, enabling them to expand their impactful work without fundraising and reporting hassles.
Until Melinda gets to know us and learns that the C/Can model works, I will continue working closely with all our partners.
Because cancer care requires a cross-sector commitment to drive real and meaningful change, partnerships between the non-profit and for-profit sectors are essential. For 6 years, I’ve had the privilege of collaborating with Roche. Our journey has been incredibly rewarding, filled with challenges and breakthroughs.
After a comprehensive partnership review of our collective impact, we decided to document our journey and develop a collaboration framework between City Cancer Challenge and Roche.
We both agree this framework could help many organizations navigate cross-sector collaborations. It may not be a one-size-fits-all, but I believe it will benefit many CSOs and corporations.
Access the framework here.
Here is a short video that captures reflections from Michael Oberreiter and me on our partnership and roadmap for the next three years ahead!
Full video here.”
Source: Isabel Mestres/LinkedIn
Isabel Mestres is the CEO of the City Cancer Challenge (C/Can), previously being the Director of Global Public Affairs. She also led initiatives in membership and partnership development at the International Union for Cancer Control.
Mestres’ strategic sense positions her to propel C/Can forward, advancing its mission of enhancing cancer care accessibility in low- and middle-income nations.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023